Brain lysosomal glycosidase activity in immunosuppressed mice infected with avirulent Semliki forest virus.
Mice infected with an avirulent strain of Semliki forest virus show an increase in the activity of some of the brain lysosomal glycosidases. The increase in activity of these enzymes has been correlated with the histological, virological, and serological changes that result from the infection in the presence and absence of immunosuppression. Semliki forest virus alone caused the development of a mild encephalitis with perivascular infiltration, microgliosis, astrocyte hypertrophy, and a focal spongiform encephalopathy, together with an increased activity of brain N-acetyl-beta-D-glucosaminidase and beta-glucuronidase. Antilymphocyte serum given after infection marginally affected the course of the disease. Cyclophosphamide markedly delayed the development of the spongy changes in the increase in enzyme activities, but not the perivascular infiltration. It is suggested that the increased activity of the lysosomal glycosidases studied may be linked both to the development of a successful immune response and to the focal spongiform changes produced by the infection.
D000118:Acetylglucosaminidase / Q000378:metabolism; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001921:Brain / Q000201:enzymology* / Q000473:pathology; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D005966:Glucuronidase / Q000378:metabolism; D006026:Glycoside Hydrolases / Q000378:metabolism*; D006596:Hexosaminidases / Q000378:metabolism; D007165:Immunosuppression Therapy; D008247:Lysosomes / Q000201:enzymology; D051379:Mice; D008815:Mice, Inbred Strains; D012672:Semliki forest virus; D014777:Virus Diseases / Q000201:enzymology* / Q000276:immunology / Q000473:pathology
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D006026:Glycoside Hydrolases; D006596:Hexosaminidases; D005966:Glucuronidase; D000118:Acetylglucosaminidase